Oakworth Capital, Inc. Teva Pharmaceutical Industries LTD Transaction History

Oakworth Capital, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$8.38 - $10.18 $888 - $1,079	-106 Reduced 20.42%	413 $4,000
Q3 2019 Nov 13, 2019	SELL	$6.16 - $9.6 $19,712 - $30,720	-3,200 Reduced 86.04%	519 $3,000
Q1 2019 May 06, 2019	BUY	$15.58 - $20.01 $6,434 - $8,264	413 Added 12.49%	3,719 $58,000
Q2 2018 Aug 07, 2018	BUY	$16.77 - $24.71 $53,664 - $79,072	3,200 Added 3018.87%	3,306 $80,000
Q3 2017 Nov 08, 2017	BUY	$15.41 - $32.17 $1,633 - $3,410	106	106 $2,000

626

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $23.2B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Oakworth Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Oakworth Capital, Inc. with notifications on news.